From: ROAR-A: re-optimization based Online Adaptive Radiotherapy of anal cancer, a prospective phase II trial protocol
Dose to Tumor
Pathological LN < 20 mm
Pathological LN ≥ 20 mm
Elective areas
T1N0
T1-4 N1-3
T1-4 N1-3 (No chemo)
54 Gy/30 fx
60 Gy/30 fx
64 Gy/32 fx
-
48 Gy/30 fx
51,2 Gy/32 fx